Skip to main content
. 2020 Feb 12;17(4):1168. doi: 10.3390/ijerph17041168

Table 1.

Studies of sun exposure in relation to ovarian cancer risk (incidence).

Author, Year of Publication
[Reference]
Study Location Study Design Recruitment Period or Cohort Follow-up Years No. Cases No. Controls or Cohort Size Measure of Sun Exposure Timing of the Exposure Measurement RR (95% CI) for Highest vs Lowest Exposure Adjustment Variables Study Quality 1
Bodelon, 2012 [31] USA Population-based case control 2002–2009 1334 1679 Mean erythemal exposure (EE) based on residential history From age 25 to one year before study participation 0.97 (0.79–1.19) 2 Age, county of residence, calendar year, number of full-term pregnancies and duration of hormonal contraceptives. 8
Tran, 2012 [27] Australia Population-based case control 2002–2005 1500 1459 Average daily ambient ultraviolet radiation based on residential history From age 5 to study participation 0.73 (0.57–0.95) Age, state of residence, body mass index, ever breastfeeding, parity, use of hormonal contraceptive pills and family history of breast/ovarian cancer. 6
Qin, 2016 [28] USA Population-based case control 2010–2016 490 656 Daylight hours spent outdoors in summer months Not specified 0.71 (0.51–0.99) Age, region, total energy intake, education, parity, oral contraceptive use, menopausal status, tubal ligation, family history of breast/ovarian cancer, pigmentation, recreational physical activity, body mass index and total vitamin D intake. 7
Prescott, 2013 3 [29] USA Prospective cohort 1976–2010 970 75,613 4 Ultraviolet-B (UVB) flux based on latitude, altitude and cloud cover Baseline 1.13 (0.96–1.33) Age, duration of oral contraceptive use, number of pregnancies, tubal ligation, menopausal status, ever use of post-menopausal hormones and first-degree family history of ovarian cancer. 6
Prescott, 2013 3
[29]
USA Prospective cohort 1989–2011 255 102,904 4 UVB flux based on latitude, altitude and cloud cover Baseline 0,70 (0.53–0.93) Age, duration of oral contraceptive use, number of pregnancies, tubal ligation, menopausal status, ever use of post-menopausal hormones and first-degree family history of ovarian cancer. 6

1 Score based on the Newcastle-Ottawa Scale; 2 The category of reference is an intermediate level of exposure; 3 This study reported on two cohort studies, the Nurses’ Health Study (NHS) and the Nurses’ Health Study II (NHSII); 4 Cohort size at mid-point of follow-up.